Amedica Announces Podium Presentations and Participation at NASS 2017
October 23 2017 - 9:00AM
Silicon Nitride to be featured in several NASS
sessions
Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial
company that develops and manufactures silicon nitride as a
platform for biomedical applications, announced key podium
presentations to be made and its participation at the annual
meeting of the North American Spine Society (NASS) 2017, October 25
– 27 in Orlando, Florida. At the 2017 NASS annual meeting spine
care professionals from around the globe will share the latest
information, innovative techniques and procedures, best practices,
and new technologies.
Amedica has had three podium presentations accepted by NASS that
will be delivered by surgeon users of Amedica’s silicon nitride
products. These presentations reflect the scientific and clinical
advancements of Amedica’s innovative silicon nitride material. More
specifically, the presentations will demonstrate silicon nitride’s
innate bioactivity, osseoconductivity, and inherent antimicrobial
properties.
Additionally, the company will be exhibiting at booth #905
promoting its line of Valeo® silicon nitride spinal implants and
the Taurus™ pedicle screw system. Additional details can be found
at https://www.amedica.com/news-media/events.
Podium Presentations
Enhanced Osseoconductivity via Endocytotic Formation of
Silicon- and Nitrogen-Substituted Hydroxyapatite within the Osseous
Tissue of a Retrieved Intervertebral Spinal
SpacerPresented by: Dr. Alex Gitelman, MDDate: Wednesday,
October 25, 2017Time: 2:05 pm ESTSession: Innovative Technologies
Presentation
An Assessment of the Inherent
Antimicrobial Resistance of Biomaterials Utilized in Spinal Fusion
SurgeryPresented by: Dr. Craig Kuhns, MD Date: Friday,
October 27, 2017Time: 1:27 pm ESTSession: Abstract
Presentations- Infection
Enhanced Bioactivity and Bacteriostasis
of PEEK Polymers Through Incorporation of Silicon Nitride
ParticlesPresented by: Dr. Craig Kuhns, MDDate: Friday,
October 27, 2017Time: 1:33 pm ESTSession: Abstract Presentations-
Infection
About Amedica Corporation
Amedica is focused on the development and
application of spinal interbody implants made with medical-grade
silicon nitride ceramic. Amedica markets spinal fusion products and
is developing implants for other biomedical applications, such as
wear- and corrosion-resistant hip and knee bearings, and dental
implants. The Company’s products are manufactured in its ISO 13485
certified manufacturing facility, and it has a partnership with
Kyocera, one of the world’s largest ceramic manufacturers.
Amedica’s FDA-cleared and CE-marked spine products are currently
marketed in the U.S. and select markets in Europe and South America
through its distributor network, and OEM and private label
partnerships.
For more information on Amedica
or its silicon nitride material platform, please visit
www.amedica.com.
Forward-Looking Statements
This press release contains statements that
constitute forward-looking statements within the meaning of the
Securities Act of 1933 and the Securities Exchange Act of 1934, as
amended by the Private Securities Litigation Reform Act of 1995.
Such statements are subject to risks and uncertainties that could
cause actual results to differ materially from those contemplated
within this press release. A discussion of those risks and
uncertainties can be found in Amedica’s Risk Factors disclosure in
its Annual Report on Form 10-K, filed with the Securities and
Exchange Commission (SEC) on September 20, 2017, and in Amedica’s
other filings with the SEC. Amedica disclaims any obligation to
update any forward-looking statements.
Contacts:
Amedica IR
801-839-3502
IR@amedica.com
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Sep 2023 to Sep 2024